BEAM
Price
$17.86
Change
-$0.44 (-2.40%)
Updated
Aug 7 closing price
Capitalization
1.81B
94 days until earnings call
VRDN
Price
$16.53
Change
-$0.67 (-3.90%)
Updated
Aug 7 closing price
Capitalization
1.4B
102 days until earnings call
Interact to see
Advertisement

BEAM vs VRDN

Header iconBEAM vs VRDN Comparison
Open Charts BEAM vs VRDNBanner chart's image
Beam Therapeutics
Price$17.86
Change-$0.44 (-2.40%)
Volume$1.8M
Capitalization1.81B
Viridian Therapeutics
Price$16.53
Change-$0.67 (-3.90%)
Volume$848K
Capitalization1.4B
BEAM vs VRDN Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. VRDN commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and VRDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BEAM: $17.86 vs. VRDN: $16.53)
Brand notoriety: BEAM and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. VRDN: 117%
Market capitalization -- BEAM: $1.81B vs. VRDN: $1.4B
BEAM [@Biotechnology] is valued at $1.81B. VRDN’s [@Biotechnology] market capitalization is $1.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • VRDN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BEAM and VRDN are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -9.39% price change this week, while VRDN (@Biotechnology) price change was -5.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

VRDN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.81B) has a higher market cap than VRDN($1.4B). VRDN YTD gains are higher at: -13.772 vs. BEAM (-27.984). VRDN has higher annual earnings (EBITDA): -304.76M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. VRDN (637M). VRDN has less debt than BEAM: VRDN (21.2M) vs BEAM (158M). BEAM has higher revenues than VRDN: BEAM (63.6M) vs VRDN (302K).
BEAMVRDNBEAM / VRDN
Capitalization1.81B1.4B129%
EBITDA-399.03M-304.76M131%
Gain YTD-27.984-13.772203%
P/E RatioN/AN/A-
Revenue63.6M302K21,060%
Total Cash1.22B637M192%
Total Debt158M21.2M745%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMVRDN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBRFX13.55N/A
N/A
Neuberger Berman Real Estate Tr
JNBAX10.19N/A
N/A
JPMorgan Income Builder A
DIAYX29.72N/A
N/A
Diamond Hill Long-Short Y
DOPIX31.69N/A
N/A
BNY Mellon Opportunistic Small Cap I
GVALX14.57N/A
N/A
Gotham Large Value Institutional

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with DNLI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-3.90%
DNLI - VRDN
50%
Loosely correlated
-0.42%
AURA - VRDN
50%
Loosely correlated
-1.21%
DSGN - VRDN
49%
Loosely correlated
-8.74%
BEAM - VRDN
49%
Loosely correlated
-2.40%
IDYA - VRDN
48%
Loosely correlated
-5.16%
More